68Ga-pentixafor

N/A

Report date: 2025/12/10 11:39:56
NME

Base Information

Drug Name68Ga-pentixafor
Drug Alias Name[68Ga]Ga-PentixaFor[68Ga]Ga-PentixaFor PET/CT[68Ga]PentixaforCXCR4-PET68Ga-PTF +[10] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonistsPositron-emission tomography enhancersTomography enhancers
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsCentral Nervous System LymphomaGraft vs Host DiseaseHyperaldosteronism +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyDenmark +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesScintomicsUniversity Of Munich
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthLausanne University HospitalNational Cancer Institute
Inactive CompaniesPentixapharm AG
Active IndicationsGraft vs Host DiseaseHyperaldosteronismCushing Syndrome +[5] 
Inactive IndicationsCentral Nervous System LymphomaLymphoma, B-Cell, Marginal Zone

Other Information

ATC CodeN/A
Related LinksN/A